This pilot open trial is being done to better understand the needs of families who have lost a parent to suicide at least a year ago and who have children ages 8-14 and to develop and test Family-Prolonged Grief Treatment (F-PGT), a modification of prolonged grief therapy (PGT) as a way to help these families. PGT has been proven efficacious for adults with prolonged grief. The therapy has been adapted to include work with parents in helping their children (aged 8-14) and to include sessions with the child. All assessment and treatment sessions of the study are being conducted virtually.
Age range
8 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Total Score on Feasibility of Intervention Measure (FIM) at End of Treatment
Timeframe: End of treatment at 20 weeks
Total Score on Acceptability of Intervention Measure (AIM) at End of Treatment
Timeframe: End of treatment at 20 weeks
Change in Inventory of Complicated Grief (ICG) Total Score
Timeframe: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment
Change in Inventory for Complicated Grief-Revised for Children (ICG-RC) Total Score
Timeframe: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment
Change in Clinical Global Impression (CGI-S and CGI-I) Scores
Timeframe: Baseline; 4, 8, 12, and 16 weeks of treatment; 20 weeks assessment